Search Results for keywords:"anti-seizure medication"

Found 14 results
Skip to main content

Search Results: keywords:"anti-seizure medication"

  • Type:Notice
    Citation:86 FR 701
    Reading Time:about 9 minutes

    The Federal Motor Carrier Safety Administration (FMCSA) has decided to renew exemptions for ten individuals, allowing them to drive commercial motor vehicles even though they have epilepsy or seizure disorders, as long as they remain seizure-free and under stable treatment. These exemptions are valid for two years and enable the individuals, who are on anti-seizure medication, to continue working in interstate commerce. FMCSA ensures ongoing safety through annual medical reports and examinations, and while the exemption is in effect, states cannot enforce conflicting laws against these drivers. If any conditions are not met or if safety is compromised, the exemptions can be revoked.

    Simple Explanation

    Some truck drivers who take medicine for seizures got special permission to keep driving trucks, as long as they don't have any seizures and their doctors say they are safe. They have to get checked every year, and if they're not safe anymore, they won't be allowed to drive.

  • Type:Notice
    Citation:90 FR 13982
    Reading Time:about 6 minutes

    The Federal Motor Carrier Safety Administration (FMCSA), part of the Department of Transportation, has decided to renew exemptions for 19 drivers with a history of epilepsy or seizures. These exemptions allow these individuals, who are on anti-seizure medication, to continue driving commercial motor vehicles (CMVs) across state lines. The FMCSA evaluated these drivers' applications and found that granting the exemptions will maintain a level of safety equal to or greater than the current regulations. Although the public was invited to comment on these renewals, no comments were received. The exemptions are valid for two years unless revoked earlier.

    Simple Explanation

    The government is letting 19 people who take medicine for seizures keep driving big trucks across states because they've shown they can do it safely.

  • Type:Notice
    Citation:90 FR 718
    Reading Time:about 10 minutes

    The Federal Motor Carrier Safety Administration (FMCSA) has renewed exemptions for 19 drivers who have experienced seizures and are on anti-seizure medication, allowing them to continue operating commercial motor vehicles despite the usual medical restrictions. These exemptions are granted because the drivers have shown they can safely operate vehicles, and each exemption is valid for two years. The drivers must follow specific conditions, like remaining seizure-free and undergoing regular medical examinations. If any safety issues arise, FMCSA may revoke these exemptions. FMCSA is also seeking comments from the public regarding these exemptions.

    Simple Explanation

    The government is letting 19 truck drivers, who need medicine because they've had seizures before, keep driving big trucks because they've shown they can do it safely. If they don't follow the rules or have safety problems, they might lose this special permission.

  • Type:Notice
    Citation:90 FR 13987
    Reading Time:about 9 minutes

    The Federal Motor Carrier Safety Administration (FMCSA) has received applications from 11 individuals seeking an exemption from rules prohibiting people with epilepsy or seizure disorders from driving commercial motor vehicles in interstate commerce. These individuals are taking anti-seizure medication and have been seizure-free for varying periods, with support from their physicians for receiving an exemption. The agency is asking for public comments on these exemption requests by April 28, 2025. If approved, the exemptions would allow these applicants to legally operate commercial vehicles across state lines.

    Simple Explanation

    The government is thinking about letting 11 people with epilepsy, who take medicine to stop seizures, drive big trucks across state lines. They want to hear what people think about this idea by April 28, 2025.